Epigenetics and autosomal dominant polycystic kidney disease

Gabow, 1993, Autosomal dominant polycystic kidney disease, Am. J. Kidney Dis., 22, 511, 10.1016/S0272-6386(12)80921-8 Peters, 1992, Genetic heterogeneity of polycystic kidney disease in Europe, Contrib. Nephrol., 97, 128, 10.1159/000421651 Chen, 1999, Polycystin-L is a calcium-regulated cation channel permeable to calcium ions, Nature, 401, 383, 10.1038/43907 Gonzalez-Perrett, 2001, Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel, Proc. Natl Acad. Sci. USA, 98, 1182, 10.1073/pnas.98.3.1182 Hanaoka, 2000, Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents, Nature, 408, 990, 10.1038/35050128 Koulen, 2002, Polycystin-2 is an intracellular calcium release channel, Nat. Cell Biol., 4, 191, 10.1038/ncb754 Thivierge, 2006, Overexpression of PKD1 causes polycystic kidney disease, Mol. Cell. Biol., 26, 1538, 10.1128/MCB.26.4.1538-1548.2006 Chang, 2006, Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models, Nephrol. Dial. Transplant., 21, 2078, 10.1093/ndt/gfl150 Jones, 2007, Epigenetics: reversing the ‘irreversible’, Nature, 450, 357, 10.1038/450357a Strahl, 2000, The language of covalent histone modifications, Nature, 403, 41, 10.1038/47412 Luger, 2003, Structure and dynamic behavior of nucleosomes, Curr. Opin. Genet. Dev., 13, 127, 10.1016/S0959-437X(03)00026-1 Gregory, 2001, Histone acetylation and chromatin remodeling, Exp. Cell Res., 265, 195, 10.1006/excr.2001.5187 Roth, 2001, Histone acetyltransferases, Annu. Rev. Biochem., 70, 81, 10.1146/annurev.biochem.70.1.81 Lee, 1993, A positive role for histone acetylation in transcription factor access to nucleosomal DNA, Cell, 72, 73, 10.1016/0092-8674(93)90051-Q Gray, 2001, Histone acetylation/deacetylation and cancer: an “open” and “shut” case?, Curr. Mol. Med., 1, 401, 10.2174/1566524013363537 Shi, 2007, Histone lysine demethylases: emerging roles in development, physiology and disease, Nat. Rev. Genet., 8, 829, 10.1038/nrg2218 Oki, 2007, Role of histone phosphorylation in chromatin dynamics and its implications in diseases, Subcell. Biochem., 41, 319 Thiagalingam, 2003, Histone deacetylases: unique players in shaping the epigenetic histone code, Ann. NY Acad. Sci., 983, 84, 10.1111/j.1749-6632.2003.tb05964.x Bolden, 2006, Anticancer activities of histone deacetylase inhibitors, Nat. Rev. Drug Discov., 5, 769, 10.1038/nrd2133 Mariadason, 2008, HDACs and HDAC inhibitors in colon cancer, Epigenetics, 3, 28, 10.4161/epi.3.1.5736 Taplick, 2001, Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1, J. Mol. Biol., 308, 27, 10.1006/jmbi.2001.4569 Taunton, 1996, A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p, Science, 272, 408, 10.1126/science.272.5260.408 Bertos, 2001, Class II histone deacetylases: structure, function, and regulation, Biochem. Cell Biol., 79, 243, 10.1139/o01-032 Gao, 2002, Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family, J. Biol. Chem., 277, 25748, 10.1074/jbc.M111871200 Michan, 2007, Sirtuins in mammals: insights into their biological function, Biochem. J., 404, 1, 10.1042/BJ20070140 Blander, 2004, The Sir2 family of protein deacetylases, Annu. Rev. Biochem., 73, 417, 10.1146/annurev.biochem.73.011303.073651 Xu, 2007, Histone deacetylase inhibitors: molecular mechanisms of action, Oncogene, 26, 5541, 10.1038/sj.onc.1210620 Gray, 2001, The human histone deacetylase family, Exp. Cell Res., 262, 75, 10.1006/excr.2000.5080 Glozak, 2005, Acetylation and deacetylation of non-histone proteins, Gene, 363, 15, 10.1016/j.gene.2005.09.010 Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 Marzio, 2000, E2F family members are differentially regulated by reversible acetylation, J. Biol. Chem., 275, 10887, 10.1074/jbc.275.15.10887 Patel, 2004, The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60, Mol. Cell. Biol., 24, 10826, 10.1128/MCB.24.24.10826-10834.2004 Chen, 2001, Duration of nuclear NF-kappaB action regulated by reversible acetylation, Science, 293, 1653, 10.1126/science.1062374 Jeong, 2002, Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation, Cell, 111, 709, 10.1016/S0092-8674(02)01085-1 Ammanamanchi, 2003, Acetylated sp3 is a transcriptional activator, J. Biol. Chem., 278, 35775, 10.1074/jbc.M305961200 Braun, 2001, Transcription factor Sp3 is regulated by acetylation, Nucleic Acids Res., 29, 4994, 10.1093/nar/29.24.4994 Imhof, 1997, Acetylation of general transcription factors by histone acetyltransferases, Curr. Biol., 7, 689, 10.1016/S0960-9822(06)00296-X Boyes, 1998, Regulation of activity of the transcription factor GATA-1 by acetylation, Nature, 396, 594, 10.1038/25166 Waltzer, 1998, Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling, Nature, 395, 521, 10.1038/26785 Munshi, 1998, Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome, Mol. Cell, 2, 457, 10.1016/S1097-2765(00)80145-8 Ito, 2002, MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation, EMBO J., 21, 6236, 10.1093/emboj/cdf616 Ito, 2006, Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression, J. Exp. Med., 203, 7, 10.1084/jem.20050466 Gregoire, 2007, Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2, Mol. Cell. Biol., 27, 1280, 10.1128/MCB.00882-06 Hubbert, 2002, HDAC6 is a microtubule-associated deacetylase, Nature, 417, 455, 10.1038/417455a Kovacs, 2005, HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor, Mol. Cell, 18, 601, 10.1016/j.molcel.2005.04.021 Deribe, 2009, Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6, Sci. Signal., 2, ra84 Valenzuela-Fernandez, 2008, HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions, Trends Cell Biol., 18, 291, 10.1016/j.tcb.2008.04.003 Pugacheva, 2007, HEF1-dependent Aurora A activation induces disassembly of the primary cilium, Cell, 129, 1351, 10.1016/j.cell.2007.04.035 Bali, 2005, Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors, J. Biol. Chem., 280, 26729, 10.1074/jbc.C500186200 Van Bodegom, 2006, The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression, J. Biol. Chem., 281, 31234, 10.1074/jbc.M606510200 Enya, 2008, The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells, J. Leukoc. Biol., 83, 190, 10.1189/jlb.0106008 Xia, 2010, Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts, Development, 137, 1075, 10.1242/dev.049437 McKinsey, 2002, MEF2: a calcium-dependent regulator of cell division, differentiation and death, Trends Biochem. Sci., 27, 40, 10.1016/S0968-0004(01)02031-X Haberland, 2007, Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation, Mol. Cell. Biol., 27, 518, 10.1128/MCB.01415-06 Wang, 2001, The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development, Development, 128, 4623, 10.1242/dev.128.22.4623 Wang, 2009, Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS, Blood Vong, 2005, Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses, Genesis, 43, 43, 10.1002/gene.20152 Rubera, 2004, Specific Cre/Lox recombination in the mouse proximal tubule, J. Am. Soc. Nephrol., 15, 2050, 10.1097/01.ASN.0000133023.89251.01 Wu, 1998, Somatic inactivation of Pkd2 results in polycystic kidney disease, Cell, 93, 177, 10.1016/S0092-8674(00)81570-6 Fischle, 2002, Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR, Mol. Cell, 9, 45, 10.1016/S1097-2765(01)00429-4 Cao, 2009, Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models, Proc. Natl Acad. Sci. USA, 106, 21819, 10.1073/pnas.0911987106 Praetorius, 2005, A physiological view of the primary cilium, Annu. Rev. Physiol., 67, 515, 10.1146/annurev.physiol.67.040403.101353 Pan, 2007, The primary cilium: keeper of the key to cell division, Cell, 129, 1255, 10.1016/j.cell.2007.06.018 Veland, 2009, Primary cilia and signaling pathways in mammalian development, health and disease, Nephron Physiol., 111, 39, 10.1159/000208212 Cadigan, 2009, Wnt signaling from development to disease: insights from model systems, Cold Spring Harb. Perspect. Biol., 1, a002881, 10.1101/cshperspect.a002881 Kim, 1999, The polycystic kidney disease 1 gene product modulates Wnt signaling, J. Biol. Chem., 274, 4947, 10.1074/jbc.274.8.4947 Song, 2009, Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks, Hum. Mol. Genet., 18, 2328, 10.1093/hmg/ddp165 Lu, 2003, Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion, Cancer Cell, 4, 499, 10.1016/S1535-6108(03)00304-0 Li, 2008, HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization, J. Biol. Chem., 283, 12686, 10.1074/jbc.C700185200 Amit, 2002, Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway, Genes Dev., 16, 1066, 10.1101/gad.230302 Sweeney, 2006, Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease, Cell Tissue Res., 326, 671, 10.1007/s00441-006-0226-0 Du, 1995, Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD, Am. J. Physiol., 269, C487, 10.1152/ajpcell.1995.269.2.C487 Gattone, 1996, Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse, J. Lab. Clin. Med., 127, 214, 10.1016/S0022-2143(96)90081-5 Nauta, 1995, Biliary epithelial cells from mice with congenital polycystic kidney disease are hyperresponsive to epidermal growth factor, Pediatr. Res., 37, 755, 10.1203/00006450-199506000-00014 Orellana, 1995, Epidermal growth factor receptor expression is abnormal in murine polycystic kidney, Kidney Int., 47, 490, 10.1038/ki.1995.62 Richards, 1998, Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease, J. Clin. Invest., 101, 935, 10.1172/JCI2071 Sweeney, 1998, Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease, Am. J. Physiol., 275, F387 Kamemura, 2008, Effects of downregulated HDAC6 expression on the proliferation of lung cancer cells, Biochem. Biophys. Res. Commun., 374, 84, 10.1016/j.bbrc.2008.06.092 Mai, 2009, New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme- and cell-based investigations, Int. J. Biochem. Cell Biol., 41, 235, 10.1016/j.biocel.2008.09.002 Sweeney, 2008, Src inhibition ameliorates polycystic kidney disease, J. Am. Soc. Nephrol., 19, 1331, 10.1681/ASN.2007060665